Analysis on the Causes and Countermeasures of Business Risks in Health Industry Companies - Based on a Comparative Analysis of Ali Health, United Health Group and Novo Nordisk

Zhenzi Li (), Yuting Pan and Junyi Zheng
Additional contact information
Zhenzi Li: Soochow University, Business School
Yuting Pan: Broward College, Business Administration and Management
Junyi Zheng: Broward College, Business Administration and Management

A chapter in Proceedings of the 9th International Conference on Financial Innovation and Economic Development (ICFIED 2024), 2024, pp 458-466 from Springer

Abstract: Abstract The health industry has always been an important part of the global economy. In recent years, with the improvement of people's living standards, people pay more and more attention to health and quality of lives. After an in-depth study of the market, industry and consumer demand, the health industry has shown the following development trends: health management has gradually become mainstream, the nutrition and healthcare market continue to grow, Internet healthcare has become the new normal, and personalised healthcare service has become the new direction. In the background of the health industry tends to be popular in recent years, this paper selects and analyses the financial statements and stock data of three representative companies, namely, Ali Health, United Health Group and Novo Nordisk. Finding that Novo Nordisk has the lowest business risk, United Health Group is in the middle, and Ali Health has the highest business risk, this paper selects Novo Nordisk and Ali Health as the comparative object to draw the conclusions of the study. On the basis of this research, this paper deeply analyses the causes of different degrees of business risks of the three companies and put forward corresponding countermeasures, which will provide profound guidance for the transformation and upgrading of the traditional health industry as well as for the entry of new enterprises into the health industry in the future.

Keywords: Health Industry; Market Risk; Countermeasures (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:advbcp:978-94-6463-408-2_52

Ordering information: This item can be ordered from
http://www.springer.com/9789464634082

DOI: 10.2991/978-94-6463-408-2_52

Access Statistics for this chapter

More chapters in Advances in Economics, Business and Management Research from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().